Stroke and acute Myocardial Infarction in the Thrombolytic era: Clinical correlates and long-term prognosis

Journal of the American College of Cardiology

Volumn 16, Issue 3, 1990, Pages 533-540

  O'Connor, Christopher M ^a   Califf, M ^a   Massey, Edward W ^a   Mark, Daniel B ^a   Kereiakes, Dean J ^d   Candela, Richard J ^c   Abbottsmith, Charles ^d   George, Barry ^c   Stack, Richard S ^a   Aronson, Lynne ^a   Mantell, Susan ^a   Topol, Eric J ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c RIVERSIDE METHODIST HOSPITAL   (United States)

^d CHRIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; BRAIN HEMORRHAGE; CLINICAL ARTICLE; COMPUTER ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; STROKE;

AGED; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0025041136     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(90)90338-P     Document Type: Article

References (25)

1. Myocardial infarction and stroke
2. Stroke after acute myocardial infarction: relation to infarct size
3. Myocardial infarction and stroke in the thrombolytic era
4. Administration of thrombolytic therapy in the community hospital established principles and unresolved issues
5. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
6. A prospective trial of Intravenous Streptokinase in Acute Myocardial Infarction (ISAM) mortality morbidity and infarct size at 21 days
7. Randomized trial of intravenous streptokinaae oral aspirin both or neither among 17187 cases of suspected acute myocardial infarction ISIS-2
8. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction
9. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)
10. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction results of Thrombolysis in Myocardial Infarction (TIMI) Phase II trial
11. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction
12. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction
13. A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction
14. Rescue coronary angioplasty after failure of intravenous streptokinase in acute myocardial infarction: in-hospital and long-term outcomes
15. The LOGIST procedure
16. Observation of brain embolism with special reference to the mechanisms of hemorrhagic infarction
17. Pathogenesis of hemorrhagic infarction of the brain
18. Immediate anticoagulation of embolic stroke: brain hemorrhage and management options
19. Heparin therapy for stroke: hemorrhagic complications and risk factors for intracerebral hemorrhage
20. Hemorrhagic cerebral infarction: a prospective study
21. Hypertension as a risk factor for spontaneous intracerebral hemorrhage
22. Effect of early systemic thrombolytic therapy on left ventricular mural thrombus formation in acute anterior myocardial infarction
23. Risk factor for hemorrhagic and ischemic stroke in myocardial infarct patients treated with tissue plasminogen activator (abstr)
24. Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction
25. Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase